Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TM.

J Clin Oncol. 2016 Jun 20. pii: JCO662866. [Epub ahead of print]

PMID:
27325849
2.

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.

Latimer NR, Abrams KR, Lambert PC, Morden JP, Crowther MJ.

Stat Methods Med Res. 2016 Apr 25. pii: 0962280216642264. [Epub ahead of print]

PMID:
27114326
3.

Correction: Anonymous Dermatopathologists: A Socioeconomic Solution to a Medical Problem.

Wassef C, Lambert PC, Gagna CE, Harmon G, Lambert WC.

Skinmed. 2015 Aug 1;13(4):336. eCollection 2015 Jul-Aug. No abstract available.

PMID:
26861441
4.

Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life.

Bower H, Andersson TM, Björkholm M, Dickman PW, Lambert PC, Derolf ÅR.

Blood Cancer J. 2016 Feb 5;6:e390. doi: 10.1038/bcj.2016.3.

5.

Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.

Crowther MJ, Andersson TM, Lambert PC, Abrams KR, Humphreys K.

Stat Med. 2016 Mar 30;35(7):1193-209. doi: 10.1002/sim.6779. Epub 2015 Oct 29.

PMID:
26514596
6.

Reply to Letter to the Editor by Remontet et al.

Crowther MJ, Lambert PC.

Stat Med. 2015 Nov 10;34(25):3378-80. doi: 10.1002/sim.6606. No abstract available.

PMID:
26434359
7.

Comparison of different approaches to estimating age standardized net survival.

Lambert PC, Dickman PW, Rutherford MJ.

BMC Med Res Methodol. 2015 Aug 15;15:64. doi: 10.1186/s12874-015-0057-3.

8.

Dermatopathology for fun and profit: "Updiagnosing" distresses and endangers patients and abuses their t.

Lambert WC, Lambert PC, Parish LC.

Skinmed. 2015 Mar-Apr;13(2):87-90. No abstract available.

PMID:
26137732
9.

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study.

Hultcrantz M, Wilkes SR, Kristinsson SY, Andersson TM, Derolf ÅR, Eloranta S, Samuelsson J, Landgren O, Dickman PW, Lambert PC, Björkholm M.

J Clin Oncol. 2015 Jul 10;33(20):2288-95. doi: 10.1200/JCO.2014.57.6652. Epub 2015 Jun 1.

PMID:
26033810
10.

The loss in expectation of life after colon cancer: a population-based study.

Andersson TM, Dickman PW, Eloranta S, Sjövall A, Lambe M, Lambert PC.

BMC Cancer. 2015 May 17;15:412. doi: 10.1186/s12885-015-1427-2.

11.

The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older women.

Rutherford MJ, Abel GA, Greenberg DC, Lambert PC, Lyratzopoulos G.

Br J Cancer. 2015 Mar 31;112 Suppl 1:S124-8. doi: 10.1038/bjc.2015.51.

12.

Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.

Rutherford MJ, Ironmonger L, Ormiston-Smith N, Abel GA, Greenberg DC, Lyratzopoulos G, Lambert PC.

Br J Cancer. 2015 Mar 31;112 Suppl 1:S116-23. doi: 10.1038/bjc.2015.50.

13.

Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life.

Rutherford MJ, Andersson TM, Møller H, Lambert PC.

Cancer Epidemiol. 2015 Feb;39(1):118-25. doi: 10.1016/j.canep.2014.11.002. Epub 2014 Nov 28.

PMID:
25435402
14.

Simulating Individual Patient Level Data To Address Treatment Switching When Only Summary Data Are Available.

Boucher R, Abrams K, Lambert PC.

Value Health. 2014 Nov;17(7):A579. doi: 10.1016/j.jval.2014.08.1955. Epub 2014 Oct 26. No abstract available.

15.

A general framework for parametric survival analysis.

Crowther MJ, Lambert PC.

Stat Med. 2014 Dec 30;33(30):5280-97. doi: 10.1002/sim.6300. Epub 2014 Sep 15.

PMID:
25220693
16.

Franz Kafka and the doctor's dilemma.

Lambert WC, Wassef C, Lambert PC.

Skinmed. 2014 May-Jun;12(3):139. No abstract available.

PMID:
25136737
17.

New wine in old bottles: the coming deluge of aggressive cutaneous cancers and precancers.

Wassef C, Lee B, Lambert PC, Patel L, Lambert WC.

Skinmed. 2014 May-Jun;12(3):183-5. No abstract available.

PMID:
25134315
18.

The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.

Eloranta S, Lambert PC, Andersson TM, Björkholm M, Dickman PW.

Epidemiology. 2014 Sep;25(5):742-8. doi: 10.1097/EDE.0000000000000130.

PMID:
25036430
19.

The sign of Leser-Trélat: is it really so?--for your eyes only.

Lavery MJ, Parish LC, Lambert PC, Lee RE, Lambert WC.

Skinmed. 2014 Mar-Apr;12(2):76-8. No abstract available.

PMID:
24933843
20.

Serum selenium in relation to measures of glucose metabolism and incidence of Type 2 diabetes in an older Swedish population.

Gao H, Hägg S, Sjögren P, Lambert PC, Ingelsson E, van Dam RM.

Diabet Med. 2014 Jul;31(7):787-93. doi: 10.1111/dme.12429. Epub 2014 Mar 28.

PMID:
24606531
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk